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Purpose: The apoptosis of retinal neurons plays a critical role in the pathogenesis of diabetic retinopathy (DR), but the
molecular mechanisms underlying this phenomenon remain unclear. The purpose of this study was to investigate the
cellular localization and the expression of microRNA-29b (miR-29b) and its potential target PKR associated protein X
(RAX), an activator of the pro-apoptotic RNA-dependent protein kinase (PKR) signaling pathway, in the retina of normal
and diabetic rats.
Methods: Retinas were obtained from normal and diabetic rats within 35 days after streptozotocin (STZ) injection. In
silico analysis indicated that RAX is a potential target of miR-29b. The cellular localization of miR-29b and RAX was
assessed by in situ hybridization and immunofluorescence, respectively. The expression levels of miR-29b and RAX
mRNA were evaluated by quantitative reverse transcription PCR (qRT–PCR), and the expression of RAX protein was
evaluated by western blot. A luciferase reporter assay and inhibition of endogenous RAX were performed to confirm
whether RAX is a direct target of miR-29b as predicted by the in silico analysis.
Results: We found that miR-29b and RAX are localized in the retinal ganglion cells (RGCs) and the cells of the inner
nuclear layer (INL) of the retinas from normal and diabetic rats. Thus, the expression of miR-29b and RAX, as assessed
in the retina by quantitative RT–PCR, reflects their expression in the RGCs and the cells of the INL. We also revealed
that RAX protein is upregulated (more than twofold) at 3, 6, 16, and 22 days and downregulated (70%) at 35 days, whereas
miR-29b is upregulated (more than threefold) at 28 and 35 days after STZ injection. We did not confirm the computational
prediction that RAX is a direct target of miR-29b.
Conclusions: Our results suggest that RAX expression may be indirectly regulated by miR-29b, and the upregulation of
this miRNA at the early stage of STZ-induced diabetes may have a protective effect against the apoptosis of RGCs and
cells of the INL by the pro-apoptotic RNA-dependent protein kinase (PKR) signaling pathway.
The discovery of microRNA (miRNA) added a new layer
of  complexity  to  the  regulation  of  gene  expression  [1].
MiRNAs  are  endogenous,  noncoding  RNAs  (19–25
nucleotides  in  length)  that  regulate  gene  expression  via
binding to specific sites at the 3′-untranslated region (3′-UTR)
of the target mRNAs, thereby causing translational repression
or  mRNA  degradation.  Recent  computational  predictions
indicate that miRNAs may regulate approximately 30% of
human protein-coding genes [2]. In mammals, the functions
of specific miRNAs have been described in important cellular
processes, such as cell-cycle regulation [3] and hematopoietic
[4] and adipocyte [5] differentiation. The abnormal expression
of miRNAs has recently been associated with several diseases.
However, little is known about the role played by miRNAs in
ocular diseases [6,7].
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Diabetic retinopathy (DR) is one of the most common
complications of diabetes, and nearly all people with type 1
and more than half with type 2 diabetes develop retinopathy
[8]. Accumulating evidence indicates that apoptosis of the
retinal neurons precedes the microvascular alterations in the
retina of diabetic patients and streptozotocin (STZ)-induced
diabetic  rats  [9,10].  It  has  also  been  demonstrated  that
apoptosis of the retinal neurons plays a critical role in the
pathogenesis  of  DR  [11],  but  the  molecular  mechanisms
underlying this phenomenon are currently unclear.
Recent  findings  indicated  that  microRNA-29b
(miR-29b)  is  involved  in  apoptosis  [12,13].  Based  on  the
finding that the miR-29 family is expressed in the rat retina
[14] and that one miRNA has several targets, we hypothesize
that miR-29b could regulate the genes in the pro-apoptotic
pathways that are involved in the apoptosis of the retinal
neurons of STZ-induced diabetic rats. The activation of the
RNA-dependent  protein  kinase  (PKR)  is  reported  to  be
involved in the cell death of the retinal ganglion cells treated
with  tunicamycin  [15].  These  authors  showed  that  the
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2228activation of PKR is due to the endoplasmic reticulum (ER)
stress  induced  by  tunicamycin.  Moreover,  it  was
demonstrated that ER stress has a role in the early stage of
diabetic retinopathy [16]. Interestingly, the in silico analysis
revealed that one of the potential targets of miR-29b is RAX
(PKR-associated  protein  X),  the  only  known  physiologic
activator of PKR. It has been suggested that RAX may be a
direct  stress-sensitive  activator  of  PKR  and  could  induce
apoptosis  by  activating  the  PKR-signaling  pathway  under
stress conditions [17]. In this context, it is possible that the
sustained  hyperglycemic  state  and  consequent  ER  stress
observed in diabetes could induce the expression of RAX in
the retinal neurons of diabetic animals.
In the present study, we used STZ-induced diabetic rats
because this experimental model of diabetes displays many of
the  morphological  and  functional  changes  in  the  retinal
neurons that are evident in human DR [18]. We investigated
the cellular localization and expression of miR-29b and RAX
in the retina of normal and diabetic rats to elucidate their
possible involvement in the apoptosis of retinal neurons.
METHODS
Animals and treatment with streptozotocin: Male Wistar rats
weighing 130 to 150 g were housed in suspended wire-bottom
cages in a room kept at 25±2 °C with a 12:12 h light–dark
cycle and were provided with food and water ad libitum. The
animals were randomly divided into groups of eight. For the
induction diabetes, STZ (Sigma Chemical Co., St. Louis, MO)
was  dissolved  in  0.01  M  citrate  buffer,  pH  4.5,  and  was
injected within 5 min of its preparation. The rats were fasted
overnight, anesthetized with isoflurane, and injected with STZ
in the jugular vein at a dose of 45 mg/kg bodyweight. The
control rats were injected with the citrate buffer [19]. Blood
glucose levels were measured by the colorimetric oxidase
glucose method (Labtest, Lagoa Santa, Brazil) 24 h after the
injection of STZ or citrate buffer. Only animals with blood
glucose values ≥400 mg/dl were used. All experiments were
performed between 8:00AM and 10:00 AM The STZ-injected
and control rats were sacrificed by rapid cervical dislocation
at the indicated time points after treatment. The retinas were
dissected and used either for the analysis of RAX mRNA and
miR-29 expression and protein analysis or processed for in situ
hybridization  and  immunofluorescence.  The  care  and
treatment of the animals received prior institutional approval
(protocol 012/2008) from the Ethical Commission of Ethics
in  Animal  Research  of  the  School  of  Medicine  at  the
University of São Paulo, Ribeirão Preto, SP, Brazil.
Tissue  fixation:  For  in  situ  hybridization  and
immunofluorescence, enucleated eyes were first immersion
fixed in 4% buffered paraformaldehyde prepared in 0.2 M
phosphate buffer (pH 7.3) at 4 °C for 24 h, transferred to
cassettes, and subsequently treated with 70% ethanol for 2 h,
99% ethanol for 1 h, absolute ethanol for 30 min, xylene at
room temperature for 1 h, xylene at 37 °C for 10 min, then in
a paraffin bath at 56 °C for 1 h. The fixed samples were
subjected to vacuum pressure for 30 min and then embedded
in paraffin. The paraffin blocks were cut into 5-μm serial
sections  that  were  placed  on  SuperfrostTM  (Cole-Parmer,
Vernon Hills, IL) slides. Cellular integrity was assessed by
histological  staining  using  Harris  hematoxylin  and  eosin-
phloxine. For this, the sections were adhered to the slides in
an oven at 60 °C, deparaffinized in xylene, and rehydrated
through graded ethanol washes (100%, 95%, 80%, and 70%)
for 10 min each followed by a wash in distilled water for 5
min.  Subsequently,  the  sections  were  stained  with
hematoxylin for 1 min, washed in distilled water, and stained
with eosin for 2 min. The slides were dehydrated and mounted
in  Permount  (Fisher  Scientific,  Pittsburgh,  PA).  Other
sections  of  each  sample  were  processed  for
immunofluorescence and in situ hybridization.
Immunofluorescence: For immunostaining, the slides were
incubated  in  0.1  M  glycine  (dissolved  in  PBS:  0.01  M
phosphate-buffered saline, pH 7.4) for 30 min and blocked for
1 h in 1% goat serum, 2% BSA (BSA), and 0.05% Triton
X-100 in PBS at room temperature in a humidity chamber.
The slides were incubated in the primary anti-PACT (PKR
activator)  goat  polyclonal  antibody  (Santa  Cruz
Biotechnology, Santa Cruz, CA), diluted 1:50 in blocking
buffer under the same conditions for 3 h. After three 5-min
washes in PBS, slides were incubated in a 1:2,000 Alexa Fluor
594 rabbit antigoat fluorescent secondary antibody solution
(Molecular Probes, Invitrogen) in a humidified chamber for 1
h at room temperature in the dark. The slides were washed ten
times in PBS, mounted with Vectashield mounting medium
with with the 4',6-diamidino-2-phenylindole (DAPI; Vector
Laboratories, Burlingame, CA), and coverslips were applied.
The slides were viewed with a Leica DM5500B fluorescent
microscope  (Leica  Microsystems,  Bannockbur,  IL).  The
images were captured with the Leica DFC 340 FX software
(Leica  Microsystems)  and  processed  using  using  Adobe
PhotoShop software (Adobe Systems Inc., San Jose, CA). The
specificity of antibody staining was confirmed by incubating
the adjacent sections in the absence of the primary antibody.
In  situ  hybridization:  To  perform  in  situ  hybridization  of
miR-29b, a locked nucleic acid (LNA)-modified, digoxigenin
(DIG)-labeled  probe  was  generated  by  Exiqon  (Vedbaek,
Denmark). Such LNA probes have previously been shown to
provide exceptional miRNA hybridization specificity that is
sensitive to 1 or 2 nucleotide mismatches [20]. We optimized
the miRNA in situ hybridization protocol described by Ryan
et  al.  [21].  In  this  protocol,  deparaffinized  sections  were
treated  for  15  min  with  0.1%  H2O2  to  block  endogenous
peroxidase activity and treated for 5 min with proteinase K
(10 μg/ml) followed by 30 s in 0.2% glycine. The sections
were refixed in 4% paraformaldehyde for 10 min, washed
twice in PBS, and prehybridized for 2 h in the hybridization
buffer (50% formamide, 5×300 mM NaCl, 30 mM sodium
citrate,  pH  7.0,  0.4%  Tween,  9.2  mM  citric  acid  [pH  6],
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hybridized overnight at room temperature in the presence of
20 nM of the DIG-labeled probe. The slides were washed
twice in 2× SSC for 5 min, followed by three 30-min washes
in 50% formamide plus 2× SSC at 37 °C. After five washes
in 0.1% Triton X-100 in PBS, the slides were incubated in
blocking solution (2% sheep serum, 2 mg/ml BSA in PBST:
0.1M PBS, 0.5% Tween-20, pH 7.4) followed by an overnight
incubation at 4 °C in a 1:1,000 of anti-digoxigenin monoclonal
antibody conjugated with biotin (Abcam, Cambridge, UK).
The  slides  were  washed  seven  times  for  5  min  in  PBS.
Immunological  detection  was  performed  with  the  TSA
(Tyramide  Signal  Amplification)  Biotin  System  (Perkin
Elmer, Boston, MA) for 10 min at room temperature. The
specificity  of  the  antibody  staining  was  confirmed  by
incubating adjacent sections in the absence of the miR-29b
antibody. As a positive control, a U6 probe generated by
Exiqon was substituted for the miR-29b probe.
RNA isolation: Total RNA was extracted from the retinas of
normal and diabetic rats using Trizol-LS Reagent (Invitrogen,
Carlsbad, CA) followed by isopropanol precipitation. RNA
concentration  was  assessed  using  a  biophotometer
(Eppendorf, Hamburg, Germany), and a ratio of 2.0 for sample
absorbance at 260/280 nm was considered acceptable.
Analysis of microRNA-29b expression by quantitative reverse
transcription  PCR:  The  expression  analysis  of  mature
miR-29b  was  performed  with  quantitative  reverse
transcription  PCR  (qRT–PCR)  for  the  retina  samples  at
various  intervals  after  STZ  treatment  and  for  the  control
retinas. Briefly, 2.5 µl of total RNA (10 ng) was supplemented
with  the  RT  primer  mix  with  the  RT  primer  (TaqMan
MicroRNAs Reverse Transcription Kit, Applied Biosystems,
Foster  City,  CA).  For  β-actin  assays,  RT  reactions  were
performed  using  500  ng  of  RNA  and  random  hexamers
(Applied Biosystems). All reactions were incubated in the
Thermo Hybaid PCR Express (Middlesex, UK) at 42 °C for
1 h. After the RT reaction, the cDNA products were diluted
to 1:4. In a 10-μl PCR reaction, 4.0 µl of the diluted cDNA
was added to 5.0 μl of 2× PCR master mix (TaqMan Universal
PCR  master  mix;  Applied  Biosystems)  and  1.0  μl  of  the
miR-29b  primers  and  TaqMan  probe  mix;  Applied
Biosystems). The same procedure was used for the β-actin
assays except for the use of 4.5 µl of the diluted cDNA and
1.5  μl  of  the  human  β-actin  primers  and  probe  mix
(predeveloped  TaqMan  assay;  Applied  Biosystems).  The
reactions were incubated in a 96-well optical plate at 95 °C
for 10 min followed by 40 cycles of 95 °C for 15 s and 60 °C
for 10 min, using an Applied Biosystems 7500 Sequence
Detection  system.  The  cycle  threshold  (ΔCt)  values  were
calculated, and the data were normalized to the housekeeping
gene β-actin (ACTB) [22]. Real-time PCR was performed in
triplicate in three independent experiments, and the results
were expressed as means±standard error of the mean (SEM).
Prediction  of  microRNA-29b  targets:  We  used  three
algorithms  to  computationally  predict  potential  targets  of
miR-29b.  The  algorithms  included  miRanda,  TargetScan
5.0, and FindTar. The computationally predicted miRNA–
target pairs were downloaded to a local database. We selected
the best predicted targets of miR-29b by comparing the results
from the three target prediction databases [23].
Analysis  of  the  PKR  activator  RAX  mRNA  expression  by
quantitative  reverse  transcription  PCR:  Standard  SYBR
Green qRT–PCR was performed to detect the RAX transcript
levels  in  the  total  cellular  RNA  from  the  retinas  of  the
hyperglycemic  and  the  normoglycemic  rats.  After  RNA
isolation, 1.2 µg of RNA from the individual samples was
reverse  transcribed  using  the  Superscript  III  Reverse
Transcriptase Kit (Invitrogen). The quantitative PCR (qPCR)
assays were performed using an Applied Biosystems 7500
Sequence Detection system. The thermal cycling conditions
for PCR were as follows: 95 °C for 3 min and 40 cycles of
amplification comprising 95 °C for 12 s, 60 °C for 30 s, and
72 °C for 30 s. The reaction mixture consisted of 2 µl cDNA,
SYBR Green PCR Master Mix (Applied Biosystems), and
primers to RAX (sense 5′-AGC GGG ACC TTC AGT TTG
G-3′  and  antisense  5′-CTT  GGT  CTT  CGT  GCC  GTA
CTC-3′). These primers were specific for the published RAX
cDNA  sequence  (GenBank  NM_001024780.1),  designed
using  Primer  Express  version  2  software  (Applied
Biosystems), and optimized for use at a final concentration of
2.5 µM. ACTB mRNA was analyzed in the same run using
specific primers (sense 5′-TGG AAT CCT GTG GCA TCC
ATG AAA C-3′ and antisense 5′-TAA AAC GCA GCT CAG
TAA CAG TCC G-3′) as recommended by the manufacturer
(Applied Biosystems). The Ct values were calculated, and the
data were normalized to the housekeeping gene mRNA levels
(ACTB).  qPCR  was  performed  in  triplicate  in  three
independent  experiments  with  ±SEM  reported.  A  linear
standard curve analysis for each primer pair at a maximum of
a 10−6 dilution of the control-pooled cDNA and a primer
amplification efficiency (E) greater than 0.96 was obtained
for all the PCR experiments. The heat dissociation of the
amplified DNA detected a single peak in all cases, indicating
that a single specific PCR product had been synthesized. This
was confirmed by electrophoresis of the PCR products in
which a single band of the expected molecular weight was
observed.
Western blot analysis: The retinas were lysed directly on ice
in 200 µl of lysis buffer consisting of 20 mM Tris-HCl (pH
7.6), 50 mM KCl, 400 mM NaCl, 1 mM EDTA, 0.2 mM
phenylmethylsulfonyl fluoride, 2 μg/ml aprotinin, 2 μg/ml
leupeptin, 1 mM dithiothreitol, 1% Triton X-100, and 20%
glycerol.  The  reagents  used  to  prepare  lysis  buffer  were
purchased from Sigma Chemical Co., St. Louis, MO. The
lysates were centrifuged at 10,000 ×g for 20 min, and the
supernatant was stored at −70 °C. The soluble proteins were
quantitated following the Lowry method [24]. Total cellular
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2230proteins (30 μg) were separated by electrophoresis through a
10% sodium dodecyl sulfate PAGE (SDS–PAGE)-resolving
gel with an SDS–PAGE stacking gel. After electrophoresis,
the  proteins  were  transferred  onto  a  Hybond-C-supported
nitrocellulose  membrane  (Amersham  Biosciences,  Little
Chalfont, UK) by semidry electroblotting. The membranes
were blocked with 3% BSA in 100 mM Tris–HCl, pH 7.5,
100 mM NaCl, 0.1% Tween-20 (TBST) for 1 h and incubated
in a 1:300 dilution anti-PACT goat polyclonal antibody (Santa
Cruz Biotechnology) in blocking buffer for 1 h. After washing
the membranes in TBST for 20 min, 1:2,000 dilution rabbit
antigoat immunoglobulin secondary antibody conjugated to
horseradish  peroxidase  (Amersham  Biosciences)  in  TBST
was  added,  and  the  membranes  were  incubated  at  room
temperature for 60 min. After washing the membranes for 1
h  min  in  diluted  in  TBST,  Enhanced  Chemiluminescence
(ECL)  Detection  Reagents  (Amersham  Biosciences,  Little
Chalfont, UK) were added to the membranes for 2 min, and
the  membranes  were  developed  on  Hyperfilm  (GE
Healthcare, UK). The western blots were repeated three times;
qualitatively similar results were obtained each time. Equal
loading  and  transfer  were  ensured  by  reprobing  the
membranes for β-actin. The films were documented and the
bands  were  analyzed  by  densitometry  using  ImageJ
software. The bar graphs were plotted using GraphPad Prism
4.02 software (GraphPad, San Diego, CA).
Luciferase reporter assay: The reporter plasmid containing
the miR-29b complementary sequence was constructed with
a  fragment  of  the  3′UTR  of  RAX  mRNA  containing  the
predicted miR-29b binding site. This fragment was amplified
by RT–PCR using primers (sense 5′-GCT GAG TGT GGC
ATC CAT TT-3′ and antisense 5′-CCA CTT CAC AAA GCT
TTG CAC-3′) that produced a 141-bp amplicon spanning
nucleotides 189–330 and containing one potential target site
for  miR-29b.  The  amplicon  was  cloned  in  the  pCR®  2.1
TOPO  vector  (Invitrogen)  to  incorporate  the  SacI–XbaI
restriction enzyme sites. After the appropriate digestion and
purification (QIAquick Gel Extraction and PCR Purification
Kit; Qiagen), the product was subcloned into the XbaI site of
site of pISO [25,26], downstream of the firefly luciferase-
coding sequence, to generate the pISORAX plasmid. The
plasmid was purified (Plasmid Purification Mini/Midi Kits;
Qiagen),  and  successful  cloning  was  confirmed  by  DNA
sequencing. For transfection, human embryonic kidney cells
(HEK293)  were  seeded  in  complete  Dulbecco’s  minimal
essential medium (DMEM; Gibco-Invitrogen, Paisley, UK)
supplemented  with  15%  fetal  bovine  serum  (Dominique
Dutscher, Brumath, France) in 24-well plates at a density of
5×104 cells per well. After 24 h, the cells were transfected with
Lipofectamine 2000 reagent (Invitrogen), 100 ng of the pISO
reporter  construct  (pISO-REPORT-3′-UTR/RAX  or  pISO-
REPORT  empty),  20  ng  of  the  Renilla  luciferase  control
vector,  pRL-TK  (Promega,  Lyon,  France);  and  either  a
synthetic miR-29b mimic (Dharmacon, Denmark) or a short
double-stranded RNA (dsRNA; Dharmacon), as a negative
control at two doses (50 nM or 75 nM). The sequence (5′-GAT
AGC AAT GAC GAA TGC GTA-3′) of the dsRNA control
is not complementary to the 3′-UTR of RAX mRNA. The
efficiency of transfection was monitored by reporter activity,
which  was  measured  using  the  dual  luciferase  assay  kit
(Promega) and a luminometer (Lecteur Microplaque-Mithras
LB940). We measured firefly luciferase activity 24 and 48 h
after transfection and normalized the results to the Renilla
luciferase activity. We performed at least three independent
experiments for each assay, and the results were expressed as
the mean±SEM.
Analysis of protein and mRNA expression levels of RAX, an
activator of PKR, in the presence of a microRNA-29b mimic:
To confirm the results of the luciferase reporter assay, CJ4 rat
fibrosarcoma cells were seeded in six-well plates at a density
of 1×106 cells/well in DMEM supplemented with 15% fetal
bovine serum. After 24 h, when they reached a confluence of
80%–85%, the cells were transfected at two doses (50 nM and
75 nM) with either the synthetic miR-29b mimic or the dsRNA
negative control (described above) and 30 µl of Lipofectamine
(Invitrogen, Carlsbad, CA) 2000. The cells were lysed at 24
and 48 h after transfection. Protein expression levels and RAX
mRNA  expression  levels  were  assessed  by  western  blot
analysis and qRT–PCR, using the standard procedures already
mentioned.  We  performed  at  least  three  independent
experiments for each assay, and the results were expressed as
the mean±SEM.
Statistical  analysis:  Data  are  presented  as  mean±SEM.
Differences between the control and the treated retinas were
assessed  with  the  paired  Student  t  test,  and  p<0.05  was
considered statistically significant. Analysis of the data was
performed  with  GraphPad  Prism  4.0  software  (GraphPad
Software, Inc., San Diego, CA) and Microsoft Excel.
RESULTS
Cellular localization of microRNA-29b in the retina: We used
in situ hybridization to determine the cellular localization of
miR-29b in the retina of diabetic rats. The cellular localization
of miR-29b is shown in the control rat retinas (Figure 1A) and
the diabetic rat retinas on days 6 (Figure 1B), 28 (Figure 1C),
and 35 (Figure 1D) post-STZ injection. The miR-29b signal
was  weak  at  6  days  but  strong  at  28  and  35  days.  The
miR-29b staining was observed in the cytoplasm, and there
was no change in the cellular localization of miR-29b in the
retina of normal and diabetic rats.
Expression of microRNA-29b in retina: The distribution of
miR-29b was strongest and primarily seen in the ganglion cell
layer  (GCL).  Very  little  signal  was  detected  in  the  inner
nuclear layer (INL), and little if any expression was detected
in the outer nuclear layer (Figure 1C,D). The analysis of the
expression of miR-29b in the retina by qRT–PCR reflects the
expression seen in the RGCs and cells of the INL, as indicated
Molecular Vision 2011; 17:2228-2240 <http://www.molvis.org/molvis/v17/a242> © 2011 Molecular Vision
2231in Figure 1C. We observed that miR-29b is upregulated (>3
fold) at 28 (p=0.01) and 35 (p=0.05) days after injection of
STZ  (Figure  2).  The  expression  profiles  of  miR-29a  and
miR-29c were similar to that found for miR-29b (data not
shown).
Computational prediction of potential microR-29b targets:
The results of the computational analysis indicated that one
of the miR-29 targets is RAX mRNA. As shown in Figure 3A,
there is a region of sequence in the 3′-UTR of RAX that is
highly  conserved  across  all  mammals  and  has  identical
nucleotides from the second to the seventh base; this is known
as the “seed” sequence. The seed sequence is considered to be
the most critical sequence for selecting targets of miRNAs.
We  found  that  the  three  paralogs  of  miR-29  (miR-29a,
miR-29b, and miR-29c) have a complementary sequence to
the seed sequence on RAX with minor divergences (Figure
3B),  suggesting  that  the  three  paralogs  potentially  target
RAX mRNA. The localization of the binding sites of these
paralogs of miR-29 to on the RAX 3′-UTR overlap, and there
is only a single target site on RAX for each miRNA studied.
Cellular  localization  of  PKR  associated  protein  X  (RAX)
protein in the retina: The analysis by immunofluorescence
demonstrated  that  RAX  protein  is  expressed  in  the  same
specific  retinal  cell  types  as  that  observed  for  miR-29b
Figure 1. The cellular localization of microRNA-29b in the retina of streptozotocin (STZ)-induced diabetic rats by in situ hybridization. The
miR-29b signal was weak in the retina of diabetic rats at 6 days (B), but strong at 28 days (C) and 35 days (D) after STZ injection when
compared to normal rats (A). The negative controls (E, F, G, and H) were obtained with sections incubated in the absence of anti-digoxigenin
(DIG)-labeled probe. The positive control sections (U6 RNA) of the normal and diabetic rat retinas at 6, 28, and 35 days are I, J, K, and L,
respectively. Arrows indicate that miR-29b was expressed in the ganglion cell layer and the inner nuclear layer of the retinas. Original
magnification was 400×. The scale bar represents 50 μm. Abbreviations are as follows: GCL represents ganglion cell layer; INL represents
inner nuclear layer; ONL represents outer nuclear layer; OS represents photoreceptor outer segments. The results shown in this figure are
representative of three replicates.
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2232expression (Figure 1B and Figure 4B). The RAX-positive
cells are the same in the retinas of normal and diabetic rats
(Figure  4A,B);  however,  there  is  strong  cytoplasmic
expression  of  RAX  at  6  days  after  STZ  injection  when
compared to normal rats. In the retinas of diabetic animals at
28 and 35 days after STZ injection, RAX expression was
strongly reduced to the level of normal rats (Figure 4A,C,D).
Expression of PKR associated protein X (RAX) mRNA and
protein in the retina: PKR associated protein X (RAX) mRNA
expression in the retinal cells was significantly higher (>3.5-
fold) than that of the control group at 3 (p=0.04), 6 (p=0.004),
and  22  (p=0.001)  days  after  injection  of  STZ,  and  the
expression levels returned to that of the control by 28 days
(Figure 5A). The expression of RAX protein was increased
(>1.5 fold) at 3, 6, 15, and 22 days (p=0.001, p=0.01, p=0.002,
Figure  2.  The  expression  of
microR-29b in the retina of normal and
streptozotocin-induced  diabetic  rats.
The  mature  miR-29b  expression  was
evaluated  by  Taqman  real-time  qRT–
PCR  in  the  retinas  of  normal  and
diabetic rats. The total RNA of the retina
was reverse transcribed using miR-29b
and β-actin-specific primers, and qPCR
experiments  were  performed  as
described  in  the  methods.  The
expression of the mature miR-29b was
normalized to β-actin. Rats were used in
groups  of  three.  Data  are  means
±standard error of the mean from three
independent  experiments,  and  each
sample was run in six replicates. The
paired Student t test was performed to
ascertain  whether  there  is  statistical
significance  between  the  miR-29b
expression  levels  in  the  retinas  of
diabetic rats and nondiabetic rats. The
asterisk  (*)  indicates  statistical
significance at p<0.05.
Figure  3.  The  analysis  of  potential
microR-29b binding sites within the 3′-
UTR  of  PKR  associated  protein  X
(RAX)  mRNA.  The  bioinformatic
algorithms  TargetScan,  miRanda,  and
FindTar  were  used  to  predict  miR-29
binding  sites  in  the  3′-UTR  of  RAX
mRNA.  A:  A  map  of  the  3′-UTR  of
RAX mRNA was generated to indicate
the putative binding sites, as predicted
by the three bioinformatic algorithms.
The seed region of this common miRNA
binding site is highly conserved among
mammals. B: The diagram shows the
target  sites  for  the  microRNA-29b
(miR-29b)  paralogs  in  the  3′-
untranslated  region  (3′-UTR)  of  PKR
associates  protein  X  (RAX)  mRNA,
including the RNA hybrid-free energy
calculations and the theoretical miRNA-
mRNA  duplex  pairing.  The  colon  (:)
represents the location of a G/U wobble
base pairing.
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2233p<0.001, respectively) and decreased to a level below that of
the control group at 35 days after STZ injection (p<0.001;
Figure 5B).
Analysis  of  the  microR-29b  target  by  luciferase  reporter
assay:  To  investigate  whether  miR-29b  directly  regulates
RAX expression, we used a luciferase reporter assay. HEK293
cells were co-transfected with the plasmids (pISO-RAX or
pISO empty) and a synthetic mimic of miR-29b or dsRNA
(negative  control).  The  levels  of  luciferase  activity  were
measured at 24 and 48 h after transfection to determine the
repressive effects of this miRNA. The dual-luciferase activity
assay  revealed  that  there  was  no  difference  in  luciferase
activity between the cells transfected with the negative control
and the miR-29b oligonucleotides (Figure 6B,C).
The  effects  of  overexpression  of  microR-29b  on  PKR
associated protein X (RAX) mRNA and protein levels: When
a specific mRNA is a target of an miRNA, a change in the
concentration of the miRNA in the cell causes a change in the
amount of the mRNA and/or protein of the target in the cell.
CJ4  cells  were  transfected  with  a  synthetic  mimic  of
miR-29b or dsRNA (negative control) in concentrations of 0,
50,  and  75  nM,  and  the  expression  of  RAX  protein  was
evaluated  at  24  and  48  h  after  transfection.  The  results
revealed no significant changes in the protein expression of
Figure  4.  The  cellular  localization  of  PKR  associated  protein  X  (RAX)  in  the  retinas  of  streptozotocin-induced  diabetic  rats  by
immunofluorescence. The retinas of diabetic rats show a strong cytoplasmic expression of RAX at 6 days (B) after STZ injection when
compared to normal rats (A). The RAX expression in the retinas of diabetic animals at 28 days (C) and 35 days (D) after STZ injection was
strongly reduced to the level of normal rats (A). The nuclei of cells (E, F, G, and H) were stained with the 4',6-diamidino-2-phenylindole
(DAPI, blue) and the negative controls sections (I, J, K, and L) were incubated without the anti-RAX antibody. The negative control sections
(incubated without the anti-RAX antibody) of the normal (I) and diabetic rat retinas at 6, 28, and 35 days are J, K, and L, respectively. Arrows
indicate that RAX protein was expressed in the ganglion cell layer and the inner nuclear layer of the retina. The original magnification was
400×. The scale bar represents 50 μm. Abbreviations are as follows: GCL represents ganglion cell layer; INL represents inner nuclear layer;
ONL represents outer nuclear layer; SRS represents subretinal space. The results shown in this figure are representative of three replicates.
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2234RAX (Figure 7A,B). Although there is little information [27]
in the literature showing the regulation of gene expression by
miRNAs in mammalian cells through the degradation of the
mRNA target, we decided to investigate this possibility in our
system. With this objective, CJ4 cells were transfected in the
same conditions above and the total RNA was extracted from
the transfected cells at 24 and 48 h. The analysis by qRT–PCR
revealed that there was no significant change in the expression
level of RAX mRNA (Figure 8).
DISCUSSION
It was previously demonstrated that RGCs undergo apoptosis
in  STZ-induced  diabetic  rats  [9,10].  Recent  studies  have
indicated  that  miR-29b  is  involved  in  apoptosis  [12,13];
therefore,  the  first  step  was  to  investigate  the  cellular
localization of miR-29b in the retinas of normal and diabetic
animals.  We  observed,  by  in  situ  hybridization,  that
miR-29b is highly expressed in the neurons of the RGC of
diabetic rats. The analysis of the expression of miR-29b in the
retina by qRT–PCR showed that miR-29b is upregulated at 28
Figure  5.  PKR  associated  protein  X
(RAX) expression in the retinas of rats
after treatment with streptozotocin. A:
RAX mRNA expression was evaluated
by  qRT–PCR  and  was  normalized  to
ACTB. B: RAX protein expression was
evaluated  by  western  blot  using  anti-
RAX  antibody.  Rats  were  used  in
groups  of  three.  Data  are  means
±standard error of the mean from three
independent  experiments,  and  each
sample was run in six replicates. C: The
immunoblot  is  representative  of  one
typical experiment. For both the mRNA
and the protein levels of RAX, the paired
Student t test was performed to ascertain
whether there is statistical significance
between the retinas of diabetic rats and
nondiabetic rats. The asterisks (*, ** and
***)  indicate  statistical  significance
(p<0.05,  p<0.005  and  p<0.0005,
respectively)  between  control  and
experimental groups.
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2235and 35 days after STZ injection. Considering the localization
results from in situ hybridization, it is reasonable to assume
that the miR-29b expression detected by qRT–PCR reflects its
expression in RGCs and the cells of the INL of the rat retina.
The next step was to examine the potential targets of
miR-29b, as it is known that several miRNAs regulate an
overlapping set of target genes [12,13,28]. The computational
prediction programs suggested that RAX is a target of the
miR-29  family  (miR-29a,miR-29b,  and  miR-29c),  and
miR-29b  showed  the  highest  score  of  prediction.  It  was
reported  that  RAX,  an  activator  of  PKR,  and  its  human
ortholog PACT are 98% identical and ubiquitously expressed
in mammalian cells [17,29]. Recently, several studies have
shown that RAX is upregulated during cellular stress [17,
30-32]. Moreover, it was found that PKR plays a role in the
regulation  of  important  cellular  processes,  including  the
apoptosis of RGCs and neurons in patients with Parkinson,
Alzheimer, and Huntington’s diseases [33-37]. Interestingly,
PKR is a stress-responsive kinase, and it has been described
that apoptosis in mammalian cells occurs in response to stress
[15]. Thus, it was found that PKR has a significant role in ER
stress-dependent apoptosis through the eIF-2α/ATF4/CHOP
signaling pathway [38]. These authors also observed that ER
stress does not induce PKR expression but rather activates the
pre-existing PKR via the induction of the PKR-activating
protein  PACT.  More  recently,  it  was  suggested  that
hyperglycemia induces ER stress in the tubular cells of the
kidney  in  patients  with  established  diabetic  nephropathy
[39].  In  addition,  the  intracellular  accumulation  of
glucosamine observed in the cells of diabetic animals may
promote  the  misfolding  of  proteins  in  the  ER  lumen  and
consequently  ER  stress  [40].  On  the  basis  of  these
observations, we speculated that RAX is upregulated in the
retinal  neurons  of  STZ-induced  diabetic  rats.  To  test  this
hypothesis, we investigated the cellular localization and the
expression  of  RAX  protein  in  the  retina  of  STZ-induced
diabetic rats.
Clearly,  the  miRNA  and  its  mRNA  target  must  be
expressed in the same cells, and they are expected to have an
inverse correlation of expression. The analysis of the cellular
localization of RAX by immunofluorescence indicated that
RAX is also strongly expressed in the neurons of the ganglion
cell layer of the retinas of diabetic animals. These findings
suggest that, if the miR-29b target site in the 3′-UTR of RAX
mRNA is accessible in vivo, the expression of RAX may be
negatively  regulated  by  miR-29b.  Interestingly,  the
Figure 6. Luciferase reporter assay. A: The firefly luciferase reporter construct (pISORAX plasmid) contains a partial-length 3′-UTR of RAX
mRNA in the 5′ to 3′ orientation with respect to the firefly-luc open reading frame with the firefly luciferase start and stop codons and the
potential miR-29 target site. The pISORAX plasmid contains the partial-length 3′-UTR of RAX mRNA in the 5′ to 3′ orientation with respect
to the firefly-luc open reading frame. The firefly luciferase start and stop codons and the potential miR-29 target site are also shown. HEK293
cells were co-transfected with pISO (B) or pISORAX (C) and pRL-TK together with a synthetic miR-29b mimic or dsRNA as a negative
control. The indicated concentrations refer to the quantity of miR-29b mimic or dsRNA used for the transfection. The luciferase activity of
firefly-luc and Renilla-luc were measured at 24 h and 48 h after transfection. The firefly-luc activity was normalized to Renilla-luc expression.
Data are means±standard error of the mean from three independent experiments, each containing three replicates.
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2236upregulation of miR-29b at 28 and 35 days after the injection
of  STZ  is  accompanied  by  the  downregulation  of  RAX
protein.  This  suggests  that  RAX  expression  is  negatively
regulated by miR-29b and may represent a mechanism of
protection of retinal neurons against apoptosis, which occurs
around 35 days after STZ-induced diabetes [41]. Recently it
was found that miR-29b has a protective effect against the
deposition of extracellular matrix in the trabecular meshwork
cells when induced by chronic oxidative stress, as observed
in glaucoma [15].
To gain more insight into the role played by miR-29b in
the retina during the early stage of STZ-induced diabetes, we
investigated whether RAX is a direct target of miR-29b. The
luciferase assay and the overexpression of miR-29b did not
validate RAX as a direct target of miR-29b. Thus, it is possible
that in the retina of diabetic rats miR-29b is acting on another
target rather than RAX or this PKR activator is an indirect
target  of  miR-29b.  Not  all  the  targets  predicted  by
computational programs are experimentally validated [42]. In
addition, an inverse correlation of expression of an miRNA
and its putative target may suggest that miRNAs function
indirectly. Moreover, it has been observed that miRNAs act
as  indirect  regulators  of  gene  expression  through  the
regulation of transcription factors [43]. It is estimated that
approximately a quarter of the putative targets of miRNAs are
transcription  factors,  suggesting  that  changes  in  the
Figure  7.  PKR  associated  protein  X
(RAX) expression in the presence of a
microRNA-29b mimic. The expression
of  RAX  protein  was  evaluated  by
western blot analysis. A: The expression
of RAX protein in CJ4 cells transfected
with a miR-29b mimic at a concentration
of 0, 50, or 75 nM after 24 and 48 h of
transfection. B: The expression of RAX
protein  in  CJ4  cells  transfected  with
dsRNA  (negative  control)  at  a
concentration of 0, 50, or 75 nM, 24 and
48 h after transfection. β-actin was used
as a loading control. Rats were used in
groups  of  three.  Data  are  means
±standard error of the mean from three
independent  experiments,  and  each
sample was run in six replicates. The
immunoblot  is  representative  of  one
typical experiment.
Figure  8.  PKR  associated  protein  X
(RAX)  mRNA  expression  in  the
presence  of  a  microRNA-29b  mimic.
The  expression  of  RAX  mRNA  was
evaluated  by  qRT–PCR  in  CJ4  cells
transfected with an miR-29b mimic or
dsRNA  (negative  control)  at  a
concentration of 50 or 75 nM, 24 h (A)
and  48  h  (B)  after  transfection.
Nontransfected CJ4 cells were used as a
control. Data are means±standard error
of  the  mean  from  three  independent
experiments,  each  containing  three
replicates.
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2237expression of an miRNA may modulate the activity of specific
transcription  factors  and  alter  gene  regulatory  circuits  in
physiologic and pathological conditions [44].
Recently,  it  was  reported  that  miR-29b  indirectly
regulates DNA methyltransferase 1 (DNMT1) by targeting
the transcription factor Sp1 which binds to the GC boxes in
the  promoter  of  the  DNMT1  gene  in  mice  and  humans
[45-47].  Interestingly,  the  promoter  of  PACT  and  RAX
contains GC boxes, indicating that the expression of these
PKR  activators  is  regulated  by  Sp1  [48].  These  findings
prompted us to perform in silico analysis to search binding
sites for miR-29b in the 3′-UTR of rat Sp1 mRNA. Our results
revealed that the binding sites for miR-29b are conserved in
human and rat, suggesting that miR-29b may also regulate
Sp1  expression  in  rat  (data  not  shown).  It  should  be
emphasized that Sp1 is involved in the transcription of several
genes regulated by miR-29b [28].
Based  on  the  results  of  this  work  and  that  from  the
literature, it is reasonable to speculate that RAX expression is
indirectly regulated by miR-29b in the retinal neurons of the
rat (Figure 9). Thus, the downregulation of RAX protein that
was observed in the rat retina at 28 and 35 days after injection
of STZ could be explained by the inhibition of Sp1 expression
due  to  the  upregulation  of  miR-29b.  Moreover,  the
downregulation  of  RAX  could  result  in  a  decrease  of  the
activated PKR level with subsequent reduction of the activity
of the pro-apoptotic PKR signaling pathway. It is important
to  note  that  the  apoptosis  of  the  retinal  neurons  in  our
experimental model of diabetes occurs around 35 days after
STZ  injection  [10].  Therefore,  it  is  possible  that  the
upregulation of miR-29b at 28 and 35 days may represent part
of an adaptive response to protect the retinal neurons against
apoptosis  by  the  PKR  signaling  pathway  in  diabetic  rats.
However, additional experiments are required to confirm our
working hypothesis, such as the validation of rat Sp1as a direct
target of miR-29b and the evaluation of the expression of
Sp1  and  phosphorylated  (activated)  Sp1  in  the  retinas  of
normal and diabetic rats. The levels of activated Sp1 should
be  examined  to  determine  if  the  phosphorylation  of  pre-
existing Sp1 can explain the apparently miR-29b-independent
induction of RAX observed at 6 days after injection of STZ.
Figure  9.  Overview  of  the  proposed
mechanism  by  which  microR-29b
indirectly  regulates  the  expression  of
PKR associated protein X (RAX) in the
retinal neurons of the rat. According to
our  hypothesis,  the  upregulation  of
miR-29b in retinal neurons of diabetic
rats may result in down-regulation of
RAX  which  decreases  the  activated
PKR level with subsequent reduction of
the activity of the pro-apoptotic PKR
signaling pathway. Abbreviations: Sp1
represents  transcription  factor
Specificity  protein  1;  miR-29b
represents  microRNA-29b;  RAX
represents  PKR  associated  protein  X;
PKR  represents  RNA-dependent
protein kinase.
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2238To our knowledge, this is the first evidence for miRNA
involvement in the apoptosis of retinal neurons. It should be
emphasized  that  the  apoptosis  of  retinal  neurons  plays  a
crucial role in the pathogenesis of DR [9,10]. Moreover, our
results  provide  a  new  focus  for  future  studies  and  may
contribute  to  the  development  of  new  strategies  for  the
treatment  of  DR,  such  as  the  intravitreal  injection  of
miR-29b. Recent studies suggest a potentially therapeutic use
of miRNAs and small interfering RNAs for human diseases.
This represents a promising and exciting area of biomedical
research.
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